Case MDL No. 2754 Document 89 Filed 02/15/17 Page 1 of 2 

UNITED STATES JUDICIAL PANEL 

on 

MULTIDISTRICT LITIGATION 

IN RE: ELIQUIS (APIXABAN) PRODUCTS 

LIABILITY LITIGATION MDL No. 2754 

(SEE ATTACHED SCHEDULE) 

CONDITIONAL TRANSFER ORDER (CTO -1) 

On February 7, 2017, the Panel transferred 18 civil action(s) to the United States District Court for 

the Southern District of New York for coordinated or consolidated pretrial proceedings pursuant to 

28 U.S.C. § 1407. See _F.Supp.3d_ (J.P.M.L. 2017). Since that time, no additional action(s) have 

been transferred to the Southern District of New York. With the consent of that court, all such 

actions have been assigned to the Honorable Denise L Cote. 

It appears that the action(s) on this conditional transfer order involve questions of fact that are 

common to the actions previously transferred to the Southern District of New York and assigned to 

Judge Cote. 

Pursuant to Rule 7.1 ofthe Rules ofProcedure ofthe United States Judicial Panel on Multidistrict 

Liti~ation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the 

Southern District of New York for the reasons stated in the order of February 7, 2017, and, with the 

consent of that court, assigned to the Honorable Denise L Cote. 

This order does not become effective until it is filed in the Office of the Clerk of the United States 

District Court for the Southern District ofNew York. The transmittal of this order to said Clerk shall 

be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the 

Panel within this 7-day period, the stay will be continued until further order of the Panel. 

Inasmuch as no objection is 

pending at this time, the 

stay is lifted. 

I Feb 15, 20171 

CLERK'S OFFICE UNITED STATES 

JUDICIAL PANEL ON 

MULTIDISTRICT LITIGATION 

FOR THE PANEL: 

~ Jeffery N. Li.ithi 

Clerk of the Panel 

A CERTIFIED COPY 

RUBY. J. K.RAJICK, CLERK 

BY~~w Depu Clerk 

Case 3:17-cv-00074-JD Document 30 Filed 02/22/17 Page 1 of 2
Case MDL No. 2754 Document 89 Filed 02/15/17 Page 2 of 2 

IN RE: ELIQUIS (APIXABAN) PRODUCTS 

LIABILITY LITIGATION MDL No. 2754 

SCHEDULE CT0-1- TAG-ALONG ACTIONS 

C.A.NO. 

ARIZONA 

AZ 4 16-00802 

CALIFORNIA CENTRAL 

GAb ~ 16 98ll§ 

GAb ~ 16 981;;!4 

GAb ~ 16 98LB 

GAb ~ 16 98tH 

GAb ~ 16 99§16 

GAb ~ r7 99~§4 

GAb ~ 16 g;;;;;;gg 

GAb ~ 16 9;;!6;;!1 

GAb % 16 91988 

CALIFORNIA EASTERN 

17 9999§ 

CALIFORNIA NORTHERN 

CAN 3 17-00074 

CALIFORNIA SOUTHERN 

LOUISIANA EASTERN 

LAE 

LAE 

2 

2 

16 92711 

16 92719 

16-15940 

17-00543 

CASE CAPTION 

Bowers v. Bristol-Myers Squibb Company et al 

Or:ra Lebastehi v. McKesson Corporation et al Opposed 2114/17 

Gabriel Dellutri v. McKesson Corporation et al Opposed 2/14/17 

Dolores \Villiam:s v. McKesson Corporation et alOpposed 2/14/17 

Mariano Aguirre et al v. McKesson Corporation et al opposed 2/14/17 

John Barsky et al ¥.McKesson Corporation et al Opposed 2/14/17 

Johnny Jackson et al v. McKesson Corporation et al opposed 2/14/17 

Judy Hayes v. McKesson Corporation et al Opposed 2/14/17 

Vlilliam Altare et al v. McKesson Corporation et al opposed 21 14117 

Nanna Stuart v. McKesson Corporation et al Opposed 2/14/17 

Stark et al v. McKesson Corporation et al Opposed 2/14/17 

Margot Baker et al v. McKesson Corporation et al 

Quarg v. McKesson Corporation et al 

Fonger et al v. McKesson Corporation et al 

Opposed 2/14/17 

Opposed 2/14/17 

Walker, et al v. Bristol-Myers Squibb Company, et al 

Tudela v. Bristol-Myers Squibb, et al 

Case 3:17-cv-00074-JD Document 30 Filed 02/22/17 Page 2 of 2